The five-year survival rate for women treated for stage II breast cancer at Albany Medical Center is nearly 7 percent higher than the average of other academic medical institutions, according to data released by the American College of Surgeons.
In addition, Albany Med follows best practices for treatment of breast and colon cancer at rates far higher than cancer treatment centers both in New York State and across the country.
“Albany Medical Center’s breast program provides a multidisciplinary approach to meet each individual patient’s needs,” said Donna Pietrocola, MD, FACS, chief of the section of breast and endocrine surgery. “We have state-of-the-art technologies and a full range of surgical capabilities as well as the support of medical and radiation oncologists to provide the best possible care and outcomes for patients battling breast cancer.”
“Patients who receive treatments for their cancers at Albany Med can be assured that they are being treated by a world-class team of specialists who follow the best practices available and collaborate to find the most appropriate patient-specific therapy to allow for the greatest chance of success,” said Ankesh Nigam, MD, director of the surgical oncology program.
The nationwide oncology outcomes database is used to track and analyze data to explore trends in cancer care, create regional and state benchmarks for participating hospitals, and serve as the basis for quality improvement. The report reflects data from 2010, the most recent full year available. Issued by the American College of Surgeons Commission on Cancer (COC), the survey includes data from nearly 1,400 COC-accredited cancer treatment centers across the country, including 70 within New York State.